Markers of subclinical atherosclerosis in the ten-year risk estimation of cardiovascular events

Autor: P. V Bovtyushko, S. L Grishaev, A. Ye Filippov, A. G Obrezan

Publikováno v: КардиоСоматика, Vol 6, Iss 4, Pp 12-16 (2015)

The information content of SCORE model in the evaluation of the total ten-year cardiovascular risk in an isolated sample of 207 males without clinical manifestations of atherosclerosis was investigated. It was revealed that the most of the observatio

Externí odkaz: https://doaj.org/article/db99da5c85144f4798ed1f0289c60aaa

Aortic and carotid intima-media thickness in term small-for-gestational-age newborns and relationship with prenatal signs of severity

Autor: Monica Cruz-Lemini, Iosifina Stergiotou, Fatima Crispi, Brenda Valenzuela-Alcaraz, Eduard Gratacós, Bart Bijnens

Publikováno v: ULTRASOUND IN OBSTETRICS & GYNECOLOGY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Recercat. Dipósit de la Recerca de Catalunya

Objective To assess carotid and aortic intima–media thickness (IMT) in term small‐for‐gestational‐age (SGA) newborns with and without prenatal signs of severity. Methods This prospective study comprised 67 cases diagnosed prenatally and 134 n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48164ce8b30fea41bd842e080ddb6a8
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7217

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly

Autor: COLAO, ANNAMARIA, LOMBARDI, GAETANO, P. Marzullo, the Italian lanreotide study group

Publikováno v: European journal of endocrinology. 146(3)

OBJECTIVE: To evaluate the effect of a 6-month treatment with slow-release lanreotide (LAN) on cardiovascular risk and atherosclerosis in 24 normotensive patients with active acromegaly (GH=67.4 +/- 12.6 mU/l, IGF--I=866.0 +/- 55.8 microg/l) and 24 h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da6687d71fdd43c4fa4dc111fa89ad7
https://pubmed.ncbi.nlm.nih.gov/11888835

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.